|
George is a senior managing director at Eureka. Over the past 25 years, George has been a sought-after financial strategist to the life sciences industry with over 100 diverse transactional assignments. Prior to Eureka, he was a managing director of Arthur Andersen’s Healthcare Corporate Finance practice and a principal of Kidd & Company, Inc. Prior to founding his own firm, he was a vice president with L. William Teweles & Co., an M&A advisor specialized in agribusiness and biotechnology and a senior consultant with Battelle-Columbus, a billion-dollar contract R&D firm. George has co-authored over 80 technical and trade publications and the book entitled Genetic Engineering: Future Trends and Problems. He has also written commentaries for Nature Bio/Technology, Seed World, and Landscape & Nursery Digest. During his career he has served on the editorial boards of Genetic Technology News and High-Tech Marketing Review and delivered over 200 public presentations. George received his Ph.D. and M. A. in Cell Biology from Harvard University and holds an M.B.A. in Finance (Beta Gamma Sigma) from the Kellogg School at Northwestern University and a B.A., (magna cum laude, Phi Beta Kappa, High Honors in Biology) from Vanderbilt University. He was a National Science Foundation Fellow at California Institute of Technology and a post-doctoral Fellow in Biology at the Oak Ridge National Laboratory. He is a Registered Securities Principal (Series 24) and a Registered Securities Representative (Series 7 and 63) through the NASD. | 